Joel F. Farley - Concepedia

Author

Joel F. Farley

University of North Carolina at Chapel Hill ORCID

Also Known As

Blalock, Susan J., Curtis, Jeffrey R., Dusetzina, Stacie B., Ellis, Alan R., Farley, J.F., Farley, Joel, Farley, Joel F, Farley, Joel F., Ferreri, Stefanie P., Frail, Caitlin K.

215

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

University of North Carolina at Chapel Hill University of Minnesota Auburn University Duke Medical Center Harvard University

About

Joel F. Farley is an author at University of North Carolina at Chapel Hill specializing in medicine, public health, and health services research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	759
2	Public Health	14	15	698
3	Nursing	4	4	278
4	Health Sciences	2	2	35
5	Management	1	1	41

Joel F. Farley

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
A comparison of comorbidity measurements to predict healthcare expenditures. Joel F. Farley, Carolyn Harley, Joshua W. Devine PubMed Unique PrescriptionsElixhauser IndexHealth Care FinanceHospital MedicinePrimary Care	2006	199
Effectiveness and Safety of Dabigatran and Warfarin in Real‐World US Patients With Non‐Valvular Atrial Fibrillation: A Retrospective Cohort Study Julie C. Lauffenburger, Joel F. Farley, Anil K. Gehi, Journal of the American Heart Association	2015	154
Copayment Reductions Generate Greater Medication Adherence In Targeted Patients Matthew L. Maciejewski, Joel F. Farley, John C. Parker, Health Affairs Health Insurance DesignPharmacotherapyHarm ReductionPrimary CarePreventive Medicine	2010	116
Treating Depression After Initial Treatment Failure Bradley N. Gaynes, Stacie B. Dusetzina, Alan R. Ellis, Journal of Clinical Psychopharmacology	2011	79
Completeness of prescription information in US commercial claims databases Julie C. Lauffenburger, Akhila Balasubramanian, Joel F. Farley, Pharmacoepidemiology and Drug Safety	2013	69
A retrospective cohort study of economic outcomes and adherence to monotherapy with metformin, pioglitazone, or a sulfonylurea among patients with type 2 diabetes mellitus in the united states from 2003 to 2005 Richard A. Hansen, Joel F. Farley, M. Droege, Clinical Therapeutics Family MedicineDiabetes ManagementRetrospective Cohort StudyDiabetes EpidemiologyEconomic Outcomes	2010	65
A basis for a visual language for describing, archiving and analyzing functional models of complex biological systems Daniel L. Cook, Joel F. Farley, Stephen J. Tapscott Genome biology	2001	64
Factors Driving Anticoagulant Selection in Patients With Atrial Fibrillation in the United States Julie C. Lauffenburger, Joel F. Farley, Anil K. Gehi, The American Journal of Cardiology ThrombosisCardiovascular DiseaseMedicineAnticoagulantCoagulopathy	2015	64
Prescriber Continuity and Medication Adherence for Complex Patients Richard A. Hansen, Corrine I. Voils, Joel F. Farley, Annals of Pharmacotherapy	2014	61
Medication use and medical comorbidity in patients with chronic hepatitis C from a US commercial claims database Julie C. Lauffenburger, Christina Lourdes Mayer, Roy L. Hawke, European Journal of Gastroenterology & Hepatology	2014	49

Page 1